Skip to main content
Premium Trial:

Request an Annual Quote

Bionano Genomics Receives Nasdaq Warning Over Low Share Price

NEW YORK – Bionano Genomics has again fallen out of compliance with Nasdaq listing requirements.

According to an April 24 filing with the US Securities and Exchange Commission, the genome mapping firm received a letter from Nasdaq on April 22, stating that for 30 consecutive days, its share price had closed below the $1.00 minimum required for continued listing.

At the close of the market on April 24, shares of Bionano traded at $.35.

This is the second noncompliance notice the San Diego-based firm has received from Nasdaq since August 2019, when it was notified that its stockholders' equity did not satisfy continued listing requirements. In October, the firm raised approximately $18 million in a public offering as part of its efforts to regain compliance.

Bionano shares fell below the $1.00 threshold on March 6, a day after the firm reported fourth quarter and full year 2019 financial results. That day, the firm also amended a loan agreement with Innovatus Life Science Lending Fund. Later that month, the firm registered an offering of 17.6 million shares of common stock and warrants to purchase the same number of shares.

Bionano has until December 28 to regain compliance. Ordinarily, the company would have 180 days, but due to the recent extraordinary market conditions, Nasdaq determined to extend the compliance period.

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.